Curis (CRIS) Common Equity (2010 - 2026)
Curis (CRIS) reported Common Equity of $12.7 million for Q1 2026, up 292.33% on a YoY basis from $3.2 million in Q1 2025, and up 132.64% quarter-over-quarter from $5.5 million in Q4 2025.
Curis (CRIS) Common Equity (2010 - 2026) Analysis & Trends
Curis has reported Common Equity for 17 years, with the latest figure at $12.7 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 292.33% year-over-year to $12.7 million; the trailing twelve-month figure through Mar 2026 stood at $12.7 million (up 292.33% YoY), and the FY2025 full-year result was $5.5 million, up 191.06% from the prior year.
- Common Equity for Q1 2026 stood at $12.7 million, up from $5.5 million in the prior quarter.
- The five-year high for Common Equity was $76.0 million in Q1 2022, with the low at -$14.7 million in Q3 2025.
- Historically, Common Equity has averaged $19.4 million across 5 years, with a median of $12.7 million in 2026.
- Annual changes were most pronounced in 2025 — Common Equity tumbled 1915.27% — and 2026, when it surged 292.33%.
- Curis' Common Equity stood at $46.6 million in 2022, then slumped by 57.75% to $19.7 million in 2023, then sank by 130.49% to -$6.0 million in 2024, then jumped by 191.06% to $5.5 million in 2025, then jumped by 132.64% to $12.7 million in 2026.
- The last three Common Equity figures came in at $12.7 million (Q1 2026), $5.5 million (Q4 2025), and -$14.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 13.21 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 12.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.71 Mn |
| Dec 31, 2025 | 5.46 Mn |
| Sep 30, 2025 | -14.69 Mn |
| Jun 30, 2025 | -13.99 Mn |
| Mar 31, 2025 | -6.61 Mn |
| Dec 31, 2024 | -6.00 Mn |
| Sep 30, 2024 | -8.74 Mn |
| Jun 30, 2024 | -694,000.00 |
| Mar 31, 2024 | 9.46 Mn |
| Dec 31, 2023 | 19.67 Mn |
| Sep 30, 2023 | 29.59 Mn |
| Jun 30, 2023 | 26.23 Mn |
| Mar 31, 2023 | 36.59 Mn |
| Dec 31, 2022 | 46.55 Mn |
| Sep 30, 2022 | 55.75 Mn |
| Jun 30, 2022 | 62.05 Mn |
| Mar 31, 2022 | 75.97 Mn |
| Dec 31, 2021 | 90.71 Mn |
| Sep 30, 2021 | 102.91 Mn |
| Jun 30, 2021 | 112.47 Mn |